Spring Creek Capital’s STAAR Surgical STAA Stock Holding History

Spring Creek Capital’s Portfolio STAA Stock Details STAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-9,128	Closed	-$283K	–	596
2018 Q2	$283K	Buy	+9,128	New	+$214K	0.03%	668

Other funds holding STAA

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Spring Creek Capital's STAA Position: Q3 2018 in Review

Spring Creek Capital sold out of STAAR Surgical (STAA) in Q3 2018, closing a stake of 9,128 shares — an estimated $283K sold.

Spring Creek Capital first reported a position in STAA in Q2 2018 and held it in 1 quarter. The position peaked at $283K in Q2 2018. 194 funds tracked by Wall St. Rank hold STAA as of Q3 2018.

Spring Creek Capital reported no remaining STAAR Surgical position as of Q3 2018 after selling out during the quarter.
Spring Creek Capital sold 9,128 STAAR Surgical shares in Q3 2018, an estimated $283K.
Spring Creek Capital first reported a position in STAAR Surgical in Q2 2018 and held it in 1 quarter.
Spring Creek Capital's STAAR Surgical position peaked at $283K in Q2 2018.
194 funds tracked by Wall St. Rank held STAAR Surgical as of Q3 2018.

Based on Spring Creek Capital's 13F filing for Q3 2018, filed 13 Nov 2018.